CHICAGO, Dec 22 (Reuters) - The U.S. Food and Drug Administration said on Tuesday AstraZeneca's (AZN.L) MedImmune unit is voluntarily recalling some of its H1N1 swine flu vaccine because it was not as potent as it should be.
Norman Baylor, director of the office of vaccines research and review at the FDA, said the recall involves a total of 4.7 million doses of the company's nasal spray vaccine, but only about 3,000 of those doses are left in warehouses.
Asked by Anonymous at 7:53 PM on Dec. 22, 2009 in Politics & Current Events
Answer by 29again at 8:09 PM on Dec. 22, 2009
Answer by Soniam301 at 7:58 PM on Dec. 22, 2009
Answer by mancosmomma at 8:03 PM on Dec. 22, 2009
Answer by Anonymous at 8:03 PM on Dec. 22, 2009
Answer by rjpetty605 at 8:07 PM on Dec. 22, 2009
Answer by Anonymous at 10:54 PM on Dec. 22, 2009
Since this has been the 2nd recall and much larger than the first, I wouldn't bother with a booster. For all we know they are all faulty.
H1N1 is disappearing around the country, and turned out to be not much of anything. So much for the scary pandemic.
Answer by Anonymous at 11:50 PM on Dec. 22, 2009
Really? Wow its a good thing that it was really an overblown thing to distract people from the House of Representatives voting on the healthcare bill
Answer by Anonymous at 9:42 AM on Dec. 23, 2009
Answer by enetsala at 9:14 PM on Dec. 23, 2009